Generics 3

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vinorelbine manufacturers

3 products found

Filters

Filters

Filters , active

Country of origin : Argentina

Clear all

3 products found

vinorelbine

Solution for injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
EU GMP, ANVISA
Unavailable markets
Iran , Sudan , Syria , South Korea
Available for
Licensing with supply, Distribution only
Manufacturer #11475
The company is situated in South America and over time has expanded producing oncology drugs for Latin America, Asia Pacific, Europe, and North America, including the United States. The goal of the company is to develop and produce high-quality oncology generics and generics with value-added technology or super generics. Part of the goal is also to produce efficient processes that allow us to have competitive prices.

Manufacturer usually replies in 4 days

vinorelbine

Solution for injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

vinorelbine

Capsules 20 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

What is the Vinorelbine drug?

Vinorelbine is a third-generation vinca alkaloid. It is used as a chemotherapy medication to treat several types of cancers, such as breast cancer and non-small cell lung cancer. Vinorelbine disrupts the normal function of microtubules and stops cell division.
Vinorelbine was created by Pierre Potier at the CNRS in France in the 80s. The Vinorelbine drug was approved in France in 1989 and 1994 by the FDA. In 2003, the US agreed on marketing generics for Vinorelbine.
Vinorelbine medicine is on the World Health Organization's List of Essential Medicines. In most European countries, the use of Vinorelbine is allowed to treat non-small cell lung cancer and breast cancer. In the United States, it is approved only for non-small cell lung cancer.

Vinorelbine manufacturers and wholesalers:

Vinorelbine has several brand names. Vinorelbine medicine is known as Navelbine in the US and France. The first Vinorelbine manufacturer was Pierre Fabre Medicament. But now, the Vinorelbine medicine has many manufacturers such as Actavis Totowa Llc, App Pharmaceuticals Llc, Baxter Healthcare Corp Anesthesia and Critical Care, Bedford Laboratories, Ebewe Pharma, Hospira Inc, Teva Parenteral Medicines Inc.
Vinorelbine suppliers market it in the form of an oral solution or solution for injection. For the intravenous solution, Vinorelbine is available in 10 mg/mL and 50 mg/5 mL for Generics and Navelbine.

Vinorelbine for sales:

For 1 milliliter of Vinorelbine in the US, it costs from $24.62 to $30.50 and for 5 milliliters Vinorelbine costs from $17.02 to $85.10. Under the name Navelbine, one 50 mg/5 ml vial costs from $27.6 to $42.0.
As Vinorelbine is available globally, fraudulent online pharmacies may attempt to sell an illegal generic version of Vinorelbine. Thanks to Pipelinepharma online marketplace, you can be sure of the qualifications of the Vinorelbine sellers because they all have been through quality control procedures. Plus, being sure your future partner is qualified, you will save time sourcing for the product and buyer or seller, because it is all in one safe place: Pipelinepharma B2B marketplace. On the platform, you can easily place orders for any pharmaceutical products, including Vinorelbine. From our online marketplace, Vinorelbine is mostly available from Argentina, China, India, and Taiwan.

How to use Vinorelbine drugs?

To treat breast cancer, an adult should take IV: 25 mg/m2 every seven days. It is highly recommended for pregnant women not to take the Vinorelbine drug.
Taking Vinorelbine can cause some side effects such as bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, soreness, stinging, swelling, tenderness, blood in the urine.
Vinorelbine vials should be stored at 2°C to 8°C and not be frozen.